Cargando…
Delayed onset serotonin syndrome in the setting of polypharmacy
Serotonin syndrome is a rare but well-known condition that can be life-threatening if not diagnosed early. Onset is usually within 4 to 13 h of starting the offending medication. We present a case of delayed onset of serotonin syndrome that presented after 48 h. Polypharmacy played a role in causing...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850348/ https://www.ncbi.nlm.nih.gov/pubmed/33552421 http://dx.doi.org/10.1080/20009666.2020.1834929 |
_version_ | 1783645423033909248 |
---|---|
author | Acharya, Roshan Kafle, Smita Basnet, Sijan Poudel, DilliRam Ghimire, Sushil |
author_facet | Acharya, Roshan Kafle, Smita Basnet, Sijan Poudel, DilliRam Ghimire, Sushil |
author_sort | Acharya, Roshan |
collection | PubMed |
description | Serotonin syndrome is a rare but well-known condition that can be life-threatening if not diagnosed early. Onset is usually within 4 to 13 h of starting the offending medication. We present a case of delayed onset of serotonin syndrome that presented after 48 h. Polypharmacy played a role in causing the onset of symptoms. Clinicians should keep a high index of suspicion for serotonin syndrome when dealing with elderly confused patients who take multiple medications even when the onset is delayed or atypical because the outcome can be disastrous. |
format | Online Article Text |
id | pubmed-7850348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-78503482021-02-05 Delayed onset serotonin syndrome in the setting of polypharmacy Acharya, Roshan Kafle, Smita Basnet, Sijan Poudel, DilliRam Ghimire, Sushil J Community Hosp Intern Med Perspect Case Report Serotonin syndrome is a rare but well-known condition that can be life-threatening if not diagnosed early. Onset is usually within 4 to 13 h of starting the offending medication. We present a case of delayed onset of serotonin syndrome that presented after 48 h. Polypharmacy played a role in causing the onset of symptoms. Clinicians should keep a high index of suspicion for serotonin syndrome when dealing with elderly confused patients who take multiple medications even when the onset is delayed or atypical because the outcome can be disastrous. Taylor & Francis 2021-01-26 /pmc/articles/PMC7850348/ /pubmed/33552421 http://dx.doi.org/10.1080/20009666.2020.1834929 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Acharya, Roshan Kafle, Smita Basnet, Sijan Poudel, DilliRam Ghimire, Sushil Delayed onset serotonin syndrome in the setting of polypharmacy |
title | Delayed onset serotonin syndrome in the setting of polypharmacy |
title_full | Delayed onset serotonin syndrome in the setting of polypharmacy |
title_fullStr | Delayed onset serotonin syndrome in the setting of polypharmacy |
title_full_unstemmed | Delayed onset serotonin syndrome in the setting of polypharmacy |
title_short | Delayed onset serotonin syndrome in the setting of polypharmacy |
title_sort | delayed onset serotonin syndrome in the setting of polypharmacy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850348/ https://www.ncbi.nlm.nih.gov/pubmed/33552421 http://dx.doi.org/10.1080/20009666.2020.1834929 |
work_keys_str_mv | AT acharyaroshan delayedonsetserotoninsyndromeinthesettingofpolypharmacy AT kaflesmita delayedonsetserotoninsyndromeinthesettingofpolypharmacy AT basnetsijan delayedonsetserotoninsyndromeinthesettingofpolypharmacy AT poudeldilliram delayedonsetserotoninsyndromeinthesettingofpolypharmacy AT ghimiresushil delayedonsetserotoninsyndromeinthesettingofpolypharmacy |